• Production capacity of 25 million tests per annum, that can be ramped up further if required
• MDX facility with core production area of around 9,500 sq. ft., is co-located in the Diagnostics facility spread over 50,000 sq. ft.
• Designed with high sensitivity, specificity, and inclusivity, varied molecular test kits are expected to be available in a phased manner, starting from September 2021
COVID-19 pandemic has led to a heightened awareness and need for Molecular testing infrastructure in the Country. Siemens Healthineers has announced local manufacturing of molecular testing kits, including COVID-19 testing (IMDX SARS-CoV2 Multiplex RTPCR) as well as other Molecular testing kits in its state-of-art facility at Vadodara, Gujarat.
The facility was inaugurated on August 27, 2021, jointly by Mr. Krishnan Seshan, Executive Director (Finance and Administration) of Siemens Healthcare Private Limited, and Arpan Malhotra, Head of Diagnostics, Siemens Healthineers, India.
“This investment reaffirms our belief in the India growth story and our commitment to the India healthcare sector. As a pioneer in diagnostics manufacturing in India, local production of molecular testing kits is a breakthrough in scaling up testing, especially during crisis. These kits are designed and developed by Siemens Healthineers along with eminent researchers from Indian universities and research centers, reinforcing our open policy to work and to enhance our efforts in expanding precision medicine,” said Arpan Malhotra, Head of Diagnostics, Siemens Healthineers, India, on this occasion.
IMDX family of Molecular Diagnostics assays tracks infectious diseases, human genetics and oncology marker based on molecular RT-PCR technology to address equitable access to diagnostics value chain, starting with advanced genomics driven IMDX SARS-CoV2 Multiplex RTPCR kit.
The IMDX SARS-CoV2 Multiplex RTPCR kits will be produced in compliance with the guidelines prescribed by the Indian statutory bodies and confirm to the highest global standards.
Being pioneers in diagnostic manufacturing, Siemens Healthineers has maintained a high level of quality and reliability in diagnostics operations for over 40 years in India and has been consistently tracking changes in consumer demands and met most consumer requirements in right time. The existing manufacturing facility licensed as per Medical Device Rules, 2017 (MDR 2017), comprises of two product lines namely Urine Analysis strips and AUTOPAK Biochemistry Reagents. As a part of the skill development initiative, the facility also serves as a Centre of Excellence for training in Laboratory Diagnostics, Point-of-Care Testing and Diagnostic Imaging, across the South Asia region.
Download this press release 0.2 MB
Media Contact:
Pranav Patil, Siemens Healthineers, India
Email: pranav.patil@siemens-healthineers.com
Khushboo Bhadani, Siemens Healthineers, India
Email: khushboo.bhadani@siemens-healthineers.com
Mobile: 7208185374
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 66,000 employees worldwide. Further information is available at www.siemens-healthineers.com.
Siemens Healthineers in India is Great Place to Work® certified, with over 3600 employees across the nation. With 56 sales offices, two manufacturing facilities at Vadodara for the Diagnostics business and at Bengaluru for Medical Imaging Products, we are supporting healthcare providers across the entire range of patient care – from prevention and early detection to diagnosis and on to treatment and after care. With a state-of-the-art R&D center as well as a global software development center at Bengaluru, country wide sales network and a round-the-clock service set-up; we are playing a significant role in transforming care delivery in India. Further information is available at www.siemens-healthineers.co.in